Using ultrasound to enhance the effectiveness of radiation therapy for tumors
Enhancement of tumor radiation response by ultrasound-driven nanobubble stimulation
This study is exploring a new way to make radiation therapy for cancer work better by using tiny bubbles activated by ultrasound to help damage tumors more effectively while protecting healthy tissue, and it could lead to improved treatment results for cancer patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10890034 on NIH RePORTER |
What this research studies
This research investigates a novel approach to improve cancer radiation therapy by using ultrasound-activated nanobubbles to enhance the response of tumors to radiation. The method involves a pre-treatment step that disrupts the blood vessels and cellular functions within tumors, potentially leading to greater damage to cancer cells. By targeting both the vascular and tumor cells, this technique aims to increase the effectiveness of radiation therapy while minimizing damage to surrounding healthy tissues. Preliminary studies have shown promising results, indicating that this approach could significantly improve treatment outcomes for patients with cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with tumors that are being treated with radiation therapy, particularly those with breast cancer.
Not a fit: Patients with tumors that are not amenable to radiation therapy or those who are not candidates for ultrasound treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments with fewer side effects for patients undergoing radiation therapy.
How similar studies have performed: Preliminary studies have shown success with similar approaches using microbubbles, suggesting that this novel use of nanobubbles may also yield positive results.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Exner, Agata a — Case Western Reserve University
- Study coordinator: Exner, Agata a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.